-
Folate Therapy and In-Stent Restenosis and Coronary Stenting; Quinapril Reduces Markers of Oxidative Stress in the Metabolic Syndrome; Donepezil in Patients with Alzheimers
-
Breast cancer is uncommon in men. In the current report, the NCI SEER database was examined to provide much needed epidemiological data on the similarities and differences of breast cancer in males and females. In general, men with breast cancer are older and present with more advanced disease. Yet, when matched for age and stage at presentation, overall survival is quite similar between men and women with this disease.
-
Single-agent chemotherapy should be the standard arm against which experimental treatments are tested in randomized trials didicated to PS 2 patients.
-
In an observational study enabled by a powerful drug-dispensing record linkage system, statin use among a large number of patients treated with cardiovascular drugs, was associated with a 20% reduction in incipient cancer diagnosis over a seven year period. Although not a definitive answer, drugs in this class may have cancer protective properties, and certainly further investigation is warranted.
-
In a retrospective review from the Royal Victoria Hospital in Montreal, among patients with heparin-induced thrombocytopenia, those who had underlying malignancy were found to have a greater risk for thrombotic events when compared to those without malignant disease.
-
These tips for complying with the Health Insurance Portability and Accountability Act (HIPAA) are offered by Veronica A. Marsich, JD, a shareholder with the law firm of Smith Haughey in East Lansing, MI.
-
A California hospital recently saw a 250% improvement in preventing medical errors related to medications after introducing pharmacy automation. Hospital leaders say the use of bar coding and computerized physician order entry has greatly improved patient safety.
-
When employees are injured in falls, should they be sent to the emergency department or the employee health clinic?
-
A hospital in Greenville, SC, will pay nearly $9.5 million to resolve Medicare billing improprieties from 1997 through 1999 in its home health, hospice, and durable medical equipment programs, the Office of Inspector General announced recently.
-
